Target intelligence / Profile preview

Multiple cell types and signaling pathways via paracrine cargo delivery

Molecular classification
Biological Process, Intercellular Communication Mechanism
01

Overview

Multiple cell types and signaling pathways via paracrine cargo delivery refers to a sophisticated mode of intercellular communication where a donor cell secretes bioactive molecules to alter the function of nearby recipient cells. This process is primarily mediated through the release of the secretome, which includes soluble factors and extracellular vesicles (EVs) such as exosomes (Source: Nature Reviews Molecular Cell Biology, 2018). These vesicles carry a diverse cargo of proteins, lipids, and nucleic acids, including microRNAs, which can simultaneously activate multiple signaling pathways across different cell types (Source: Stem Cell Research & Therapy, 2021). In regenerative medicine, this mechanism is the primary way Mesenchymal Stem Cells (MSCs) promote tissue repair and immunomodulation without the need for direct cell engraftment. Conversely, in oncology, tumor-derived paracrine cargo can reprogram the tumor microenvironment to facilitate metastasis and drug resistance (Source: Journal of Hematology & Oncology, 2017). Because it involves a collective of molecules rather than a single entity, it is characterized as a biological process or therapeutic mechanism rather than a discrete molecular target. Therapeutic strategies often aim to either inhibit these pathways in disease states or engineer synthetic vesicles to mimic this delivery system for drug transport.

Other names
Paracrine signalingExtracellular vesicle-mediated communicationExosome-mediated cargo deliverySecretome-based signalingIntercellular communication
02

Mechanism of action

Intercellular transfer of bioactive cargo (proteins, RNAs, lipids) via extracellular vesicles or direct secretion to modulate recipient cell behavior across multiple signaling pathways.

03

Biological functions

Signal transductionCell-cell communicationTissue repairImmune modulationCargo transport
04

Disease associations

CancerInflammationCardiovascular diseaseNeurodegenerative diseaseFibrosis
05

Safety considerations

Complexity of cargo characterizationPotential for unintended systemic effectsDifficulty in standardizing biological products like exosomesRisk of promoting tumor growth if used in oncogenic contexts
06

Biomarkers

CD63CD81CD9Exosomal miRNA signaturesTSG101

Beyond the preview

Go deeper on Multiple cell types and signaling pathways via paracrine cargo delivery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cell types and signaling pathways via paracrine cargo delivery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call